BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29799193)

  • 1. Assessment of the Antigenotoxic Activity of Poly(d,l-lactic- co-glycolic acid) Nanoparticles Loaded with Caffeic Acid Phenethyl Ester Using the Ames Salmonella/Microsome Assay.
    Arasoğlu T; Derman S
    J Agric Food Chem; 2018 Jun; 66(24):6196-6204. PubMed ID: 29799193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative evaluation of antibacterial activity of caffeic acid phenethyl ester and PLGA nanoparticle formulation by different methods.
    Arasoglu T; Derman S; Mansuroglu B
    Nanotechnology; 2016 Jan; 27(2):025103. PubMed ID: 26629915
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of Antifungal Activity of Juglone (5-Hydroxy-1,4-naphthoquinone) Using a Poly(d,l-lactic-co-glycolic acid) (PLGA) Nanoparticle System.
    Arasoglu T; Mansuroglu B; Derman S; Gumus B; Kocyigit B; Acar T; Kocacaliskan I
    J Agric Food Chem; 2016 Sep; 64(38):7087-94. PubMed ID: 27600097
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antimicrobial activity of a new synthetic peptide loaded in polylactic acid or poly(lactic-co-glycolic) acid nanoparticles against Pseudomonas aeruginosa, Escherichia coli O157:H7 and methicillin resistant Staphylococcus aureus (MRSA).
    Cruz J; Flórez J; Torres R; Urquiza M; Gutiérrez JA; Guzmán F; Ortiz CC
    Nanotechnology; 2017 Mar; 28(13):135102. PubMed ID: 28266350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fabrication of Novel Bioactive Cellulose-Based Films Derived from Caffeic Acid Phenethyl Ester-Loaded Nanoparticles via a Rapid Expansion Process: RESOLV.
    Saelo S; Assatarakul K; Sane A; Suppakul P
    J Agric Food Chem; 2016 Sep; 64(35):6694-707. PubMed ID: 27548627
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing combination of artesunate with paclitaxel loaded into poly-d,l-lactic-co-glycolic acid nanoparticle for systemic delivery to exhibit synergic chemotherapeutic response.
    Tran BN; Nguyen HT; Kim JO; Yong CS; Nguyen CN
    Drug Dev Ind Pharm; 2017 Dec; 43(12):1952-1962. PubMed ID: 28724314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of chitosan-coated poly(lactic-co-glycolic acid) nanoparticles for improving oral absorption of 7-ethyl-10-hydroxycamptothecin.
    Guo M; Rong WT; Hou J; Wang DF; Lu Y; Wang Y; Yu SQ; Xu Q
    Nanotechnology; 2013 Jun; 24(24):245101. PubMed ID: 23702815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Poly(D,L-lactic-co-glycolic acid)-based artesunate nanoparticles: formulation, antimalarial and toxicity assessments.
    Dauda K; Busari Z; Morenikeji O; Afolayan F; Oyeyemi O; Meena J; Sahu D; Panda A
    J Zhejiang Univ Sci B; 2017 Nov.; 18(11):977-985. PubMed ID: 29119735
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrophilic poly (ethylene glycol) capped poly (lactic-co-glycolic) acid nanoparticles for subcutaneous delivery of insulin in diabetic rats.
    S S; S M; P S L S; S S; S B; V P
    Int J Biol Macromol; 2017 Feb; 95():1190-1198. PubMed ID: 27825822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced intracellular delivery and controlled drug release of magnetic PLGA nanoparticles modified with transferrin.
    Cui YN; Xu QX; Davoodi P; Wang DP; Wang CH
    Acta Pharmacol Sin; 2017 Jun; 38(6):943-953. PubMed ID: 28552909
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poly(lactide)-vitamin E derivative/montmorillonite nanoparticle formulations for the oral delivery of Docetaxel.
    Feng SS; Mei L; Anitha P; Gan CW; Zhou W
    Biomaterials; 2009 Jul; 30(19):3297-306. PubMed ID: 19299012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial efficacy of poly (DL-lactide-co-glycolide) (PLGA) nanoparticles with entrapped cinnamon bark extract against Listeria monocytogenes and Salmonella typhimurium.
    Hill LE; Taylor TM; Gomes C
    J Food Sci; 2013 Apr; 78(4):N626-32. PubMed ID: 23464835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.
    Pradhan R; Ramasamy T; Choi JY; Kim JH; Poudel BK; Tak JW; Nukolova N; Choi HG; Yong CS; Kim JO
    Carbohydr Polym; 2015 Jun; 123():313-23. PubMed ID: 25843864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced antitumor activity in A431 cells via encapsulation of 20(R)-ginsenoside Rg3 in PLGA nanoparticles.
    Zhang S; Liu J; Ge B; Du M; Fu L; Fu Y; Yan Q
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1734-1741. PubMed ID: 28581836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative evaluation of the degree of pegylation of poly(lactic-co-glycolic acid) nanoparticles in enhancing central nervous system delivery of loperamide.
    Kirby BP; Pabari R; Chen CN; Al Baharna M; Walsh J; Ramtoola Z
    J Pharm Pharmacol; 2013 Oct; 65(10):1473-81. PubMed ID: 24028614
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanoparticle-based topical ophthalmic formulation for sustained release of stereoisomeric dipeptide prodrugs of ganciclovir.
    Yang X; Shah SJ; Wang Z; Agrahari V; Pal D; Mitra AK
    Drug Deliv; 2016 Sep; 23(7):2399-2409. PubMed ID: 25564964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transient aggregation of chitosan-modified poly(d,l-lactic-co-glycolic) acid nanoparticles in the blood stream and improved lung targeting efficiency.
    Lee SY; Jung E; Park JH; Park JW; Shim CK; Kim DD; Yoon IS; Cho HJ
    J Colloid Interface Sci; 2016 Oct; 480():102-108. PubMed ID: 27421112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ultrafine PEG-coated poly(lactic-co-glycolic acid) nanoparticles formulated by hydrophobic surfactant-assisted one-pot synthesis for biomedical applications.
    Chu CH; Wang YC; Huang HY; Wu LC; Yang CS
    Nanotechnology; 2011 May; 22(18):185601. PubMed ID: 21415469
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Formulation and evaluation of tacrolimus-loaded galactosylated Poly(lactic-co-glycolic acid) nanoparticles for liver targeting.
    Mistry NP; Desai JL; Thakkar HP
    J Pharm Pharmacol; 2015 Oct; 67(10):1337-48. PubMed ID: 25944126
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mixture designs in the optimisation of PLGA nanoparticles: influence of organic phase composition on β-aescin encapsulation.
    Ven HV; Vandervoort J; Weyenberg W; Apers S; Ludwig A
    J Microencapsul; 2012; 29(2):115-25. PubMed ID: 22047548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.